PharmaBoardroom

Interview: Marcel Schonenberg & Michiel Lindenbergh –…

Beurs Van Berlage is an historic conference center in Amsterdam, hosting thousands of participants each year, many of them physicians, scientists, and…

Interview: Ramon Navia – Operations Director, Skanska…

Skanska Puerto Rico’s Ramon Navia discusses the challenges the sector has faced in recent years and how Skanska has adapted its services portfolio…

Interview: Colette Alma-Zeestraten – Director…

Colette Alma-Zeestraten tells PharmaBoardroom about how the Dutch Pharma Industry is adapting, how it is making use of clusters to become more…

Turkey Will Increase Its Investment In Pharma R&D

Multinational R&D investment in Turkey, particularly investment in clinical trials, has been quite limited relative to the size of the Turkish…

How Turkey made its Pharma Sector More Efficient

Over the past six years, Turkey has consistently lowered its drugs prices and guided its companies to greater efficiency. “Reference prices in…

Turkey Turns Towards Pharmaceutical Innovation

In the coming years, Turkey plans to prioritize R&D initiatives, health studies and medical innovation: that’s the core message Minister of…

Interview: Sijmen de Vries – CEO, Pharming Group, The…

Pharming Group CEO Sijmen de Vries discusses the advantages of his company’s transgenic platform for recombinant protein production, the commercial…

Interview: Henk Viëtor – CEO, Drug Discovery Factory, The…

A serial entrepreneur, Henk Viëtor founded the Drug Discovery Factory as an active venture fund focused on translating life science research into…

Interview: Mirjam Mol-Arts – Director, Pivot Park, The…

Pivot Park in Oss, the Netherlands, aims at becoming an inspiring campus for open innovation in life sciences. The CEO discusses the unique assets the…